EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+11.77%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.8B
AUM Growth
+$5.8B
(-0.69%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
16
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$54.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$37.8M |
| 3 |
iRhythm Technologies
IRTC
|
$34.5M |
| 4 |
Global E Online
GLBE
|
$22.3M |
| 5 |
Vistra
VST
|
$21.6M |
Top Sells
| 1 |
Trane Technologies
TT
|
$77.8M |
| 2 |
Transmedics
TMDX
|
$71.4M |
| 3 |
Datadog
DDOG
|
$62.8M |
| 4 |
argenx
ARGX
|
$60M |
| 5 |
GitLab
GTLB
|
$48.4M |
Sector Composition
| 1 | Healthcare | 40.6% |
| 2 | Technology | 18.78% |
| 3 | Industrials | 17.39% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
IDEX
IEX
$12.2B
| $15.4M | 0.26% |
71,587
+4,580
| +7% | +$982K |
|
102
Syndax Pharmaceuticals
SNDX
$1.42B
| $15.1M | 0.26% |
+786,990
| New | +$15.1M |
|
103
Privia Health
PRVA
$2.84B
| $15M | 0.26% |
822,438
+746,231
| +979% | +$13.6M |
|
104
Rocket Pharmaceuticals
RCKT
$363M
| $14.2M | 0.25% |
770,691
| – | – |
|
105
Cabot Corp
CBT
$4.28B
| $13.7M | 0.24% |
122,820
+20,273
| +20% | +$2.27M |
|
106
Cytokinetics
CYTK
$5.91B
| $13.4M | 0.23% |
254,148
| – | – |
|
107
Group 1 Automotive
GPI
$6.05B
| $13.4M | 0.23% |
34,943
-6,145
| -15% | -$2.35M |
|
108
Korro Bio
KRRO
$208M
| $13.1M | 0.23% |
391,166
-137,989
| -26% | -$4.61M |
|
109
Nasdaq
NDAQ
$53.7B
| $12.3M | 0.21% |
+168,546
| New | +$12.3M |
|
110
Nektar Therapeutics
NKTR
$552M
| $12.2M | 0.21% |
9,400,000
+1,870,904
| +25% | +$2.43M |
|
111
Motorola Solutions
MSI
$79.8B
| $12M | 0.21% |
+26,633
| New | +$12M |
|
112
Dyne Therapeutics
DYN
$1.97B
| $11.9M | 0.21% |
332,277
-152,723
| -31% | -$5.49M |
|
113
NetApp
NTAP
$23.2B
| $11.8M | 0.2% |
95,422
-88,834
| -48% | -$11M |
|
114
Oneok
OKE
$46.8B
| $11.7M | 0.2% |
+128,039
| New | +$11.7M |
|
|
SLN
115
Silence Therapeutics
SLN
$233M
| $11.6M | 0.2% |
+640,000
| New | +$11.6M |
|
116
GXO Logistics
GXO
$5.88B
| $11.5M | 0.2% |
221,020
+186
| +0.1% | +$9.69K |
|
117
RLI Corp
RLI
$6.16B
| $11.4M | 0.2% |
73,464
+10,841
| +17% | +$1.68M |
|
118
IDEAYA Biosciences
IDYA
$2.32B
| $10.6M | 0.18% |
335,000
| – | – |
|
119
Procept Biorobotics
PRCT
$2.18B
| $10.3M | 0.18% |
+129,000
| New | +$10.3M |
|
120
Dell
DELL
$82.2B
| $10.3M | 0.18% |
+87,041
| New | +$10.3M |
|
121
Cogent Biosciences
COGT
$1.83B
| $9.93M | 0.17% |
919,635
-479,357
| -34% | -$5.18M |
|
122
Sempra
SRE
$53.7B
| $9.71M | 0.17% |
116,084
+37,208
| +47% | +$3.11M |
|
123
Bruker
BRKR
$4.49B
| $9.04M | 0.16% |
130,843
-969
| -0.7% | -$66.9K |
|
124
Linde
LIN
$221B
| $8.97M | 0.15% |
18,808
+5,420
| +40% | +$2.58M |
|
125
Acadia Pharmaceuticals
ACAD
$4.39B
| $8.88M | 0.15% |
+577,500
| New | +$8.88M |
|